1. |
Salem AF, Bonuccelli G, Bevilacqua GA, et al. Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition. Cell Cycle, 2011, 10(21): 3692-3700.
|
2. |
Tse EY, Ko FC, Tung EK, et al. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis. J Pathol, 2012, 226(4): 645-653.
|
3. |
Higgins PT, Green S. Cochrane handbook for systematic reviews of interventions (5.0.2). London, UK: The Cochrane Collaboration, 2009.
|
4. |
罗红梅, 张蒙夏, 唐圣松, 等. Caveolin-1 表达及其与胃癌生物学行为关系的研究. 肿瘤防治杂志, 2004, 11(4): 341-343, 369.
|
5. |
高雪, 孙媛, 黄磊, 等. Caveolin-1 在胃癌组织中的表达及临床生物学意义. 癌症, 2005, 24(3): 311-316.
|
6. |
刘斌, 杨育生, 邢传平, 等. Caveolin-1 基因 mRNA 和蛋白在胃癌组织的表达. 第四军医大学学报, 2007, 28(20): 1868-1871.
|
7. |
刘茗露, 刘斌, 陈一伟, 等. KAI1 及 Caveolin-1 在胃癌组织中的表达及其意义. 中国肿瘤临床与康复, 2010, 17(4): 323-326.
|
8. |
杨聪颖, 张志梅, 王巧, 等. 胃癌组织中 Caveolin-1、 Paxillin 的表达及其临床生物学意义. 现代肿瘤医学, 2010, 18(11): 2211-2214.
|
9. |
邢敬, 刘朋伟, 彭延申, 等. 胃腺癌微环境 caveolin-1 的表达及其临床意义. 胃肠病学, 2011, 16(8): 454-458.
|
10. |
李远航, 张建国. 窖蛋白-1 与基质金属蛋白酶 2 在胃癌组织中的表达及临床生物学意义. 中华临床医师杂志: 电子版, 2011, 5(19): 5764-5767.
|
11. |
Sun GY, Wu JX, Wu JS, et al. Caveolin-1, E-cadherin and β-catenin in gastric carcinoma, precancerous tissues and chronic non-atrophic gastritis. Chin J Cancer Res, 2012, 24(1): 23-28.
|
12. |
Barresi V, Giuffre’ G, Vitarelli E, et al. Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypotheses. Virchows Arch, 2008, 453(6): 571-578.
|
13. |
Zhao X, He Y, Gao J, et al. Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer. PLoS One, 2013, 8(3): e59102.
|
14. |
Nam KH, Lee BL, Park JH, et al. Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer. Pathobiology, 2013, 80(2): 87-94.
|
15. |
He Y, Zhao X, Gao J, et al. Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer. Int J Mol Sci, 2012, 13(11): 13764-13780.
|
16. |
Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol, 2005, 288(3): C494-C506.
|
17. |
Torres VA, Tapia JC, Rodriguez DA, et al. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J Cell Sci, 2006, 119(9): 1812-1823.
|
18. |
Cohen AW, Hnasko R, Schubert W, et al. Role of caveolae and caveolins in health and disease. Physiol Rev, 2004, 84(4): 1341-1379.
|
19. |
Burgermeister E, Xing XB, Roecken CA, et al. Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Res, 2007, 67(18): 8519-8526.
|
20. |
Ye Y, Miao SH, Lu RZ, et al. Prognostic value of caveolin-1 expression in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev, 2014, 15(19): 8367-8370.
|